Latest Articles

Publication Date
Acrivon Therapeutics Advances ACR-368 in Phase 2b Trial for Endometrial Cancer and Prepares for Initial Data on ACR-2316 - Quiver Quantitative

Acrivon Therapeutics Advances ACR-368 in Phase 2b Trial for Endometrial Cancer and Prepares for Initial Data on ACR-2316 Quiver Quantitative

Published: Nov. 13, 2025, 9:25 p.m.
Clarivate Companies to Watch Report Spotlights Seven Women's Health Startups Shaping the Future of Care - Fresh Angle

Clarivate Companies to Watch Report Spotlights Seven Women's Health Startups Shaping the Future of Care Fresh Angle

Published: Nov. 13, 2025, 8:42 p.m.
‘A whole-body disease’: Why endometriosis is so difficult to diagnose and treat - YaleNews

‘A whole-body disease’: Why endometriosis is so difficult to diagnose and treat YaleNews

Published: Nov. 13, 2025, 8:01 p.m.
Endometriosis patients call for national registry - AOL.com

Endometriosis patients call for national registry AOL.com

Published: Nov. 13, 2025, 7:49 p.m.
Accused of Desecration, a Doctor Faces the End of His Life’s Work - The New York Times

Accused of Desecration, a Doctor Faces the End of His Life’s Work The New York Times

Published: Nov. 13, 2025, 7:20 p.m.
Location of Perth’s latest endo, pelvic pain clinic revealed - The West Australian

Location of Perth’s latest endo, pelvic pain clinic revealed The West Australian

Published: Nov. 13, 2025, 6:59 p.m.
N.S. woman with endometriosis had to seek surgical care in U.S. - Yahoo News Canada

N.S. woman with endometriosis had to seek surgical care in U.S. Yahoo News Canada

Published: Nov. 13, 2025, 6:06 p.m.
Clarivate Companies to Watch Report Spotlights Seven Women's Health Startups Shaping the Future of Care - Macau Business

Clarivate Companies to Watch Report Spotlights Seven Women's Health Startups Shaping the Future of Care Macau Business

Published: Nov. 13, 2025, 4:40 p.m.
Ingenus Pharmaceuticals Announces FDA Approval and Launch of First and Only Generic Equivalent to Premarin® Tablets (Conjugated Estrogens Tablets, USP) - Morningstar

Ingenus Pharmaceuticals Announces FDA Approval and Launch of First and Only Generic Equivalent to Premarin® Tablets (Conjugated Estrogens Tablets, USP) Morningstar

Published: Nov. 13, 2025, 3:15 p.m.
N.S. woman with endometriosis had to seek surgical care in U.S. - Global News

N.S. woman with endometriosis had to seek surgical care in U.S. Global News

Published: Nov. 13, 2025, 2:02 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!